These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 29477956

  • 1. An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation.
    Overbye M.
    Int J Drug Policy; 2018 May; 55():14-30. PubMed ID: 29477956
    [Abstract] [Full Text] [Related]

  • 2. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R, Grassmayr M, Macniven R, Grunseit A, Halaki M, Bauman A.
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [Abstract] [Full Text] [Related]

  • 3. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
    Morente-Sánchez J, Zabala M.
    Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
    [Abstract] [Full Text] [Related]

  • 4. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A, McNamee M.
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [Abstract] [Full Text] [Related]

  • 5. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M, Wagner U.
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [Abstract] [Full Text] [Related]

  • 6. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F, Di Trana A, Marinelli S.
    Acta Biomed; 2022 Jan 19; 92(6):e2021401. PubMed ID: 35075058
    [Abstract] [Full Text] [Related]

  • 7. Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.
    Kondric M, Sekulic D, Petroczi A, Ostojic L, Rodek J, Ostojic Z.
    Subst Abuse Treat Prev Policy; 2011 Oct 11; 6():27. PubMed ID: 21988896
    [Abstract] [Full Text] [Related]

  • 8. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A, Alaranta H, Holmila J, Palmu P, Pietilä K, Helenius I.
    Int J Sports Med; 2006 Oct 11; 27(10):842-6. PubMed ID: 16586338
    [Abstract] [Full Text] [Related]

  • 9. National doping prevention guidelines: Intent, efficacy and lessons learned - A 4-year evaluation.
    Wippert PM, Fließer M.
    Subst Abuse Treat Prev Policy; 2016 Oct 10; 11(1):35. PubMed ID: 27724975
    [Abstract] [Full Text] [Related]

  • 10. Should performance-enhancing drugs in sport be legalized under medical supervision?
    Wiesing U.
    Sports Med; 2011 Feb 01; 41(2):167-76. PubMed ID: 21244107
    [Abstract] [Full Text] [Related]

  • 11. Predicting elite Scottish athletes' attitudes towards doping: examining the contribution of achievement goals and motivational climate.
    Allen J, Taylor J, Dimeo P, Dixon S, Robinson L.
    J Sports Sci; 2015 Feb 01; 33(9):899-906. PubMed ID: 25537139
    [Abstract] [Full Text] [Related]

  • 12. Korean national athletes' knowledge, practices, and attitudes of doping: a cross-sectional study.
    Kim T, Kim YH.
    Subst Abuse Treat Prev Policy; 2017 Feb 14; 12(1):7. PubMed ID: 28196542
    [Abstract] [Full Text] [Related]

  • 13. Doping knowledge, attitudes, and practices of Ugandan athletes': a cross-sectional study.
    Muwonge H, Zavuga R, Kabenge PA.
    Subst Abuse Treat Prev Policy; 2015 Sep 22; 10():37. PubMed ID: 26395767
    [Abstract] [Full Text] [Related]

  • 14. Sports physicians and the doping crisis in elite sport.
    Hoberman J.
    Clin J Sport Med; 2002 Jul 22; 12(4):203-8. PubMed ID: 12131053
    [Abstract] [Full Text] [Related]

  • 15. Prevalence, knowledge and attitude of prohibited substances use (doping) among Saudi sport players.
    Al Ghobain M, Konbaz MS, Almassad A, Alsultan A, Al Shubaili M, AlShabanh O.
    Subst Abuse Treat Prev Policy; 2016 Apr 16; 11():14. PubMed ID: 27083557
    [Abstract] [Full Text] [Related]

  • 16. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S, Bowers LD, Fedoruk MN.
    Mo Med; 2015 Apr 16; 112(2):122-8. PubMed ID: 25958657
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Doping in sport: effects, harm and misconceptions.
    Birzniece V.
    Intern Med J; 2015 Mar 16; 45(3):239-48. PubMed ID: 25369881
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of doping use in elite sports: a review of numbers and methods.
    de Hon O, Kuipers H, van Bottenburg M.
    Sports Med; 2015 Jan 16; 45(1):57-69. PubMed ID: 25169441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.